CD44 and neoplasm: Mesenchymal-like bCSCs, characterized as CD24−/CD44+, are primarily quiescent and are localized at the tumor invasive front, whereas epithelial-like bCSCs express aldehyde dehydrogenase (ALDH) proliferatively and are located more centrally [40].